세계의 이식 시장 : 제품별, 용도별, 최종사용자별, 지역별(2025-2033년)

The global transplantation market size reached USD 17.3 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 35.7 Billion by 2033, exhibiting a growth rate (CAGR) of 7.97% during 2025-2033. The market is experiencing significant growth driven by rapid advancements in medical technologies, increasing prevalence of chronic diseases, rising initiatives by government and non-governmental organization (NGO) promoting organ donation, expansion of specialized transplantation centers, and the evolving healthcare policies and insurance coverage.

Transplantation Market Analysis:

Market Growth and Size: The market is witnessing stable growth, driven by rapid technological advancements, increasing prevalence of chronic disease, and improved healthcare policies.

Major Market Drivers: Key drivers influencing the market growth include rapid advancements in medical technologies, rising incidence of organ failure due to chronic diseases, expansion of transplantation centers, supportive initiatives by government, and evolving healthcare policies.

Key Market Trends: The key market trends involve the ongoing shift towards personalized transplantation medicine and the use of bio-engineered organs and tissues. Additionally, the increasing investment in research and development (R&D) for developing new immunosuppressive drugs and preservation solutions, is bolstering the market growth.

Geographical Trends: North America leads the market due to its advanced healthcare system, high transplantation rates, and strong organ donation networks. Other regions are also showing significant growth, fueled by the improving healthcare infrastructure and rising consumer awareness.

Competitive Landscape: The market is characterized by the active involvement of key players that are engaged in strategic mergers, acquisitions, and partnerships, focusing on expanding their product portfolios and global presence. Furthermore, companies are focusing on investing in research and development (R&D) to innovate in drug formulations, tissue engineering, and organ preservation technologies.

Challenges and Opportunities: The market faces various challenges, such as managing the organ donor shortage, ethical issues surrounding organ donation, and disparities in healthcare access across different regions. However, advancements in tissue engineering and development of policies to support equitable access to transplant services, are creating new opportunities for the market growth.

Transplantation Market Trends:

Rapid advancements in transplantation technologies

The continuous advancements and innovations in surgical techniques, immunosuppressive medications, and organ preservation that improve transplant success rates and patient outcomes are creating a positive outlook for the market growth. In line with this, the development of minimal invasive (MI) surgical methods to reduce recovery times and complications, thereby increasing the feasibility and popularity of organ transplants is positively impacting the market growth. Moreover, rapid advancements in tissue typing and matching that minimize the risk of organ rejection are fostering the market growth. Along with this, the integration of digital and artificial intelligence (AI) technologies in transplantation for more accurate and quicker organ matching, predicting patient outcomes, and managing post-transplant care is strengthening the market growth.

Increasing prevalence of chronic diseases and organ failure

The rising prevalence of chronic diseases, such as diabetes, hypertension, and heart disease, leading to an increased need for organ transplants, is one of the major factors driving the market growth. In line with this, the growing incidence of kidney failure due to diabetes and hypertension, escalating the demand for kidney transplants across the globe, is providing a thrust to the market growth. Along with this, the increasing diagnosis of heart and liver diseases, spurring the need for heart and liver transplants, is acting as a growth-inducing factor. Besides this, the growing geriatric population who are susceptible to chronic diseases leading to organ failure is creating a positive outlook for the market. Furthermore, the heightened awareness and improved diagnosis of various health conditions, facilitating early identification of patients that require transplants, is catalyzing the market growth.

Rising initiatives by government and non-governmental organizations (NGOs) to promote organ donation

The growing influence of governments and non-governmental organizations (NGOs) in promoting organ donation is positively impacting the market growth. In line with this, the increasing organization of awareness campaigns, simplified donation procedures, and supportive legislation, leading to a rise in the number of organ donors, is favoring the market growth. Besides this, the burgeoning collaboration of the government and NGOs with healthcare providers to streamline the organ donation process is stimulating the market growth. Along with this, the introduction of policies that include family consent in the donation process and the establishment of national donor registries are catalyzing the market growth. Additionally, the heightened prevalence of international collaborations to share best practices and resources in organ donation and strengthen the global transplantation network is supporting the market growth.

Expansion of transplantation centers and services

The rising growth and expansion of specialized transplantation centers and services across the globe are providing a thrust to the market growth. The specialized transplantation centers are equipped with advanced facilities and skilled professionals capable of performing complex transplant procedures. In line with this, the establishment of dedicated centers that ensure wider accessibility to transplantation services, catering to the growing patient population requiring treatment, is boosting the market growth. Additionally, the heightened focus of the centers on specialized transplants and personalized care, offering comprehensive care that includes pre-transplant counseling, advanced surgical procedures, and post-transplant follow-up and rehabilitation, is providing an impetus to the market growth. Furthermore, the expansion of the centers to rural and underserved areas, making transplantation services more accessible to a broader segment of the population, is catalyzing the market growth.

Growing healthcare policies and insurance coverage

The introduction of various government healthcare initiatives that support transplantation procedures, including funding, reimbursement policies, and insurance coverage, is providing a considerable boost to the market growth. Along with this, the increasing efforts to standardize transplant procedures and costs across various healthcare systems are also favoring the market growth. Besides this, the integration of health services that cover the cost of long-term post-operative care, including immunosuppressive medications and regular monitoring for any signs of rejection or complications, is enhancing the market growth. In addition to this, the increasing focus on equity in access to transplant services as policymakers address disparities in transplantation rates among different socio-economic groups, ethnicities, and regions is fueling the market growth.

Transplantation Industry Segmentation:

Breakup by Product:

Tissue Products

Immunosuppressive Drugs

Preservation Solution

Tissue products account for the majority of the market share

Tissue products represent the largest segment in the market due to the high demand for various types of tissues such as corneas, skin, heart valves, bones, and veins. They are employed in a broad range of applications, such as ophthalmic procedures and orthopedic and reconstructive surgeries. Moreover, rapid technological advancements in tissue engineering and grafting techniques are positively impacting the market growth. Additionally, the increasing incidence of conditions requiring tissue transplants, such as burns, trauma, and degenerative diseases, is providing an impetus to the market growth.

Immunosuppressive drugs are essential in transplantation to prevent organ rejection and maintain the long-term viability of the transplant. They include a variety of medications, such as calcineurin inhibitors, corticosteroids, anti-proliferative agents, and mTOR inhibitors. Furthermore, the continuous research and development (R&D) to improve the efficacy of the drugs while minimizing their side effects, is favoring the market growth.

Preservation solutions are critical for maintaining the viability of organs and tissues from the time of donation to transplantation. They are designed to reduce ischemic damage to organs and extend their shelf-life, which is crucial for facilitating transplants over longer distances and improving the overall success rate of transplant surgeries.

Breakup by Application:

Organ Transplantation

Tissue Transplantation

Tissue transplantation holds the largest share in the industry

Tissue transplantation holds the largest market share, as it includes a broad range of procedures, such as skin, corneas, heart valves, bones, and veins. The widespread need for tissue transplantation in various medical conditions and procedures, including burn treatments, reconstructive surgeries, and ophthalmic conditions, is creating a positive outlook for the market growth. Moreover, the increasing prevalence of chronic diseases, accidents, and age-related degenerative conditions, escalating the demand for tissue transplants, is favoring the market growth. In addition to this, rapid advances in tissue engineering and regenerative medicine that improve the outcomes of transplants are catalyzing the market growth.

Organ transplantation involves the transplantation of vital organs, such as the heart, liver, kidney, and lungs. It is driven by the critical need for organ replacements in patients with end-stage organ failure resulting from chronic diseases like diabetes, hypertension, and cardiac diseases. Organ transplantation is characterized by its high complexity and the critical nature of the procedures. The success of organ transplantation heavily depends on timely donor matching, effective immunosuppression to prevent rejection, and advanced surgical techniques.

Breakup by End User:

Hospitals

Transplantation Centers

Others

Hospitals represent the leading market segment

Hospitals represent the largest market segment due to their comprehensive healthcare services and the ability to facilitate a wide range of transplant procedures. The dominance of hospitals is attributed to their extensive infrastructure, which includes advanced surgical facilities, intensive care units (ICUs), and specialized transplant departments. Hospitals are the first point of contact for patients requiring transplants, offering services, such as initial diagnosis, evaluation, and post-transplant care. They are equipped to handle complex transplant surgeries and provide comprehensive care, including pre-operative preparation and post-operative monitoring. Additionally, hospitals have larger patient inflows, giving them a broader base for potential transplant candidates.

Transplantation centers are exclusively focused on transplant procedures and providing highly specialized care. They consist of teams of experts who are specifically trained in various aspects of transplantation, including surgeons, transplant coordinators, immunologists, and rehabilitation specialists. Transplantation centers are known for their expertise in handling complex cases and offering cutting-edge treatments, including experimental procedures and clinical trials.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest transplantation market share

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.

North America leads the transplantation market due to its advanced healthcare infrastructure, high healthcare expenditure, and robust organ donation and transplantation programs. Moreover, the region benefits from a strong presence of leading healthcare companies and research institutions that contribute to the development of innovative transplantation technologies and drugs. Furthermore, North America has one of the highest rates of organ transplantation across the globe, supported by comprehensive regulatory frameworks and a well-organized network of organ procurement organizations. Additionally, the region's focus on research and development (R&D), coupled with favorable government policies and initiatives promoting organ donation, is driving the market growth.

Europe's transplantation market is characterized by advanced healthcare systems and high standards of medical care. Furthermore, the region has a strong network of transplantation centers and a well-established regulatory framework governing organ donation and transplantation. Moreover, the increasing government funding in healthcare, the growing prevalence of chronic diseases requiring transplants, and ongoing research in transplantation medicine are favoring the market growth.

The Asia Pacific region is experiencing rapid growth in the transplantation market, fueled by the increasing prevalence of chronic diseases, improvements in healthcare infrastructure, and rising healthcare expenditures. Additionally, the growing public awareness about organ donation and government initiatives to regulate and promote organ transplantation are contributing to the market growth.

Latin America's transplantation market is growing, driven by several factors, such as the improving healthcare systems and increasing government initiatives to support organ transplantation. Moreover, rapid advancements in transplantation procedures, leading to better outcomes and post-surgery results, are creating a positive outlook for the market growth.

The Middle East and Africa region has seen substantial growth in the transplantation market due to the increasing investments in healthcare infrastructure and growing awareness about transplantation. Additionally, the rising interest in establishing more specialized transplantation centers to address regional needs and improve access to transplant care in the region is favoring the market growth.

Leading Key Players in the Transplantation Industry:

The key players are engaged in a range of strategic activities to strengthen their positions and address the growing demands of the market. They are heavily investing in research and development (R&D) to innovate in areas like immunosuppressive drugs, organ preservation solutions, and bio-engineered tissues. Furthermore, major players are involved in mergers and acquisitions, partnerships with healthcare providers, and collaborations with academic and research institutions to expand their market reach and enhance their product portfolios. Besides this, they are also engaging in initiatives to raise public awareness about organ donation and are involved in policy advocacy to improve transplantation-related healthcare policies.

The market research report has provided a comprehensive analysis of the competitive landscape. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

21st Century Medicine

AbbVie Inc.

Arthrex Inc.

Astellas Pharma Inc.

BioLife Solutions Inc.

CareDx Inc.

Novartis AG

Teva Pharmaceutical Industries Ltd.

TransMedics Inc.

Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)

Key Questions Answered in This Report

• 1. How big is the global transplantation market?
• 2. What is the expected growth rate of the global transplantation market during 2025-2033?
• 3. What are the key factors driving the global transplantation market?
• 4. What has been the impact of COVID-19 on the global transplantation market?
• 5. What is the breakup of the global transplantation market based on the product?
• 6. What is the breakup of the global transplantation market based on the application?
• 7. What is the breakup of the global transplantation market based on the end user?
• 8. What are the key regions in the global transplantation market?
• 9. Who are the key players/companies in the global transplantation market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Transplantation Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Forecast

6 Market Breakup by Product

• 6.1 Tissue Products
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Immunosuppressive Drugs
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Preservation Solution
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast

7 Market Breakup by Application

• 7.1 Organ Transplantation
  • 7.1.1 Market Trends
  • 7.1.2 Market Forecast
• 7.2 Tissue Transplantation
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast

8 Market Breakup by End User

• 8.1 Hospitals
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Transplantation Centers
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Others
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast

9 Market Breakup by Region

• 9.1 North America
  • 9.1.1 United States
    • 9.1.1.1 Market Trends
    • 9.1.1.2 Market Forecast
  • 9.1.2 Canada
    • 9.1.2.1 Market Trends
    • 9.1.2.2 Market Forecast
• 9.2 Asia-Pacific
  • 9.2.1 China
    • 9.2.1.1 Market Trends
    • 9.2.1.2 Market Forecast
  • 9.2.2 Japan
    • 9.2.2.1 Market Trends
    • 9.2.2.2 Market Forecast
  • 9.2.3 India
    • 9.2.3.1 Market Trends
    • 9.2.3.2 Market Forecast
  • 9.2.4 South Korea
    • 9.2.4.1 Market Trends
    • 9.2.4.2 Market Forecast
  • 9.2.5 Australia
    • 9.2.5.1 Market Trends
    • 9.2.5.2 Market Forecast
  • 9.2.6 Indonesia
    • 9.2.6.1 Market Trends
    • 9.2.6.2 Market Forecast
  • 9.2.7 Others
    • 9.2.7.1 Market Trends
    • 9.2.7.2 Market Forecast
• 9.3 Europe
  • 9.3.1 Germany
    • 9.3.1.1 Market Trends
    • 9.3.1.2 Market Forecast
  • 9.3.2 France
    • 9.3.2.1 Market Trends
    • 9.3.2.2 Market Forecast
  • 9.3.3 United Kingdom
    • 9.3.3.1 Market Trends
    • 9.3.3.2 Market Forecast
  • 9.3.4 Italy
    • 9.3.4.1 Market Trends
    • 9.3.4.2 Market Forecast
  • 9.3.5 Spain
    • 9.3.5.1 Market Trends
    • 9.3.5.2 Market Forecast
  • 9.3.6 Russia
    • 9.3.6.1 Market Trends
    • 9.3.6.2 Market Forecast
  • 9.3.7 Others
    • 9.3.7.1 Market Trends
    • 9.3.7.2 Market Forecast
• 9.4 Latin America
  • 9.4.1 Brazil
    • 9.4.1.1 Market Trends
    • 9.4.1.2 Market Forecast
  • 9.4.2 Mexico
    • 9.4.2.1 Market Trends
    • 9.4.2.2 Market Forecast
  • 9.4.3 Others
    • 9.4.3.1 Market Trends
    • 9.4.3.2 Market Forecast
• 9.5 Middle East and Africa
  • 9.5.1 Market Trends
  • 9.5.2 Market Breakup by Country
  • 9.5.3 Market Forecast

10 Drivers, Restraints, and Opportunities

• 10.1 Overview
• 10.2 Drivers
• 10.3 Restraints
• 10.4 Opportunities

11 Value Chain Analysis

12 Porters Five Forces Analysis

• 12.1 Overview
• 12.2 Bargaining Power of Buyers
• 12.3 Bargaining Power of Suppliers
• 12.4 Degree of Competition
• 12.5 Threat of New Entrants
• 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

• 14.1 Market Structure
• 14.2 Key Players
• 14.3 Profiles of Key Players
  • 14.3.1 21st Century Medicine
    • 14.3.1.1 Company Overview
    • 14.3.1.2 Product Portfolio
  • 14.3.2 AbbVie Inc.
    • 14.3.2.1 Company Overview
    • 14.3.2.2 Product Portfolio
    • 14.3.2.3 Financials
    • 14.3.2.4 SWOT Analysis
  • 14.3.3 Arthrex Inc.
    • 14.3.3.1 Company Overview
    • 14.3.3.2 Product Portfolio
    • 14.3.3.3 SWOT Analysis
  • 14.3.4 Astellas Pharma Inc.
    • 14.3.4.1 Company Overview
    • 14.3.4.2 Product Portfolio
    • 14.3.4.3 Financials
    • 14.3.4.4 SWOT Analysis
  • 14.3.5 BioLife Solutions Inc.
    • 14.3.5.1 Company Overview
    • 14.3.5.2 Product Portfolio
    • 14.3.5.3 Financials
  • 14.3.6 CareDx Inc.
    • 14.3.6.1 Company Overview
    • 14.3.6.2 Product Portfolio
    • 14.3.6.3 Financials
  • 14.3.7 Novartis AG
    • 14.3.7.1 Company Overview
    • 14.3.7.2 Product Portfolio
    • 14.3.7.3 Financials
    • 14.3.7.4 SWOT Analysis
  • 14.3.8 Teva Pharmaceutical Industries Ltd.
    • 14.3.8.1 Company Overview
    • 14.3.8.2 Product Portfolio
    • 14.3.8.3 Financials
    • 14.3.8.4 SWOT Analysis
  • 14.3.9 TransMedics Inc.
    • 14.3.9.1 Company Overview
    • 14.3.9.2 Product Portfolio
  • 14.3.10 Veloxis Pharmaceutical Inc. (Asahi Kasei Corporation)
    • 14.3.10.1 Company Overview
    • 14.3.10.2 Product Portfolio

Kindly, note that this only represents a partial list of companies, and the complete list has been provided in the report.